Biochemistry of drugs XXII. Pharmacokinetics of noroxyclothepine
Franc, Z.; Smolik, S.; Horesovský, O.; Hfadil, F.
Ceskoslovenska Farmacie 25(7): 227-231
1976
ISSN/ISBN: 0009-0530 PMID: 991282 Document Number: 109304
Document emailed within 1 workday
Related Documents
Francová, V.; Schlehrová, M.; Smolík, S.; Zikán, V.; Ausková, M.; Hradil, F.; Franc, Z.; Rezábek, K.; Semonský, M. 1977: Biochemistry of drugs XXIII. Substance with antineoplastic acitivity LX. Pharmacokinetics of cis-beta-4-pentoxybenzoyl-beta-bromoacrylic acid (cis: Br, H)-3H (Penberol-3H) Neoplasma 24(5): 469-474Bernareggi, A. 1995: Pharmacokinetics of chiral drugs Bollettino Chimico Farmaceutico 134(2): 63-68
Kock-Weser, J. 1975: Pharmacokinetics of antiarrhythmic drugs Cardiovascular Clinics 7(2): 191-202
Banditt, P.; Meyer, F.P.; Walther, H. 1990: The effect of cimetidine on pharmacokinetics of other drugs Die Pharmazie 45(1): 11-16
Orme, M.; Edwards, G.; Awadzi, K.; Breckenridge, A. 1990: Clinical pharmacokinetics of drugs against onchocerciasis Acta Leidensia 59(1-2): 329-342
Ráz, K.; Francová, V.; Franc, Z.; Cerný, A.; Jelínek, V.; Semonský, M. 1970: Biochemistry of drugs. XVI. Substances with antineoplastic effect. XXXVI. Absorption, tissue distribution and excretion of ethylester N--delta-(6--purinylthio) varleryl-glycylglycine-35S (Butodicine) in mice with Crocker's sarcoma 180 Neoplasma 17(1): 37-42
Sams, R.A. 1984: Principles of clinical pharmacokinetics of antimicrobial drugs Journal of the American Veterinary Medical Association 185(10): 1068-1071
Trnavský, K.; Zachar, M. 1976: A contribution to the pharmacokinetics of some of the latest salicylate drugs Casopis Lekaru Ceskych 115(18): 552-555
Van der Kleijn, E.; Baars, A.M.; Vree, T.B.; van der Dries, A. 1983: Clinical pharmacokinetics of drugs used in the treatment of status epilepticus Advances in Neurology 34: 421-440
Rylance, G. 1984: Pharmacokinetics of anticonvulsant drugs and their dosage in childhood epilepsy Recenti Progressi in Medicina 75(1): 51-65
Hirtz, J.; Schoeller, J.P. 1976: Clinical value of the determination of drugs in the blood: a new aspect of pharmacokinetics La Nouvelle Presse Medicale 5(13): 869-872
Kaye, S.B.; Workman, P.; Graham, M.A.; Cassidy, J.; Jodrell, D. 1993: Pharmacokinetics and early clinical studies of selected new drugs Cancer Surveys 17: 371-396
Dal Negro, R.; Pomari, C.; Zoccatelli, O.; Trevisan, F.; Carloni, C.; Turco, P. 1984: Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine International Journal of Clinical Pharmacology Therapy and Toxicology 22(4): 221-226
Yamada, S.; Suou, T. 2012: Pharmacokinetics and administration of drugs in patients with hepatic failure Nihon Rinsho. Japanese Journal of Clinical Medicine 70 Suppl 6(9): 348-352
Balant, L.; Gorgia, A.; Tschopp, J.M.; Revillard, C.; Fabre, J. 1976: Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality Schweizerische Medizinische Wochenschrift 106(41): 1403-1407
Brøsen, K. 1991: The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs Ugeskrift for Laeger 153(6): 417-422
Netter, P.; Bannwarth, B.; Lapicquel, F.; Demotes-Mainard, F.; Schceverbeke, T.; Gillet, P. 1993: Pharmacokinetics and pharmacodynamics of non steroidal anti-inflammatory drugs in synovial fluid Agents and Actions. Supplements 44: 45-50
Pfeifer, S. 1991: The effect of disease states on the pharmacokinetics of drugs. 2. Liver and biliary diseases Die Pharmazie 46(9): 623-632
Jullien, V.; Lortholary, O. 2006: Pharmacokinetics-pharmacodynamics of antifungal drugs. Consequences for therapeutic drug monitoring Therapie 61(3): 209-217
Belpaire, F. 1987: Effect of inflammation on blood protein binding, pharmacokinetics and pharmacodynamics of drugs Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 49(1): 83-97